Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma

Evolution of portal vein tumor thromboses in patients with hepatocellular carcinoma: CT findings and transition of serum tumor markers

(2012) Il Soo Chang et al.   CLINICAL IMAGING

New Serum Markers of Hepatocellular Carcinoma

(2012) Ryota Masuzaki et al.   SEMINARS IN ONCOLOGY

Hepatocellualar Carcinoma Serum Markers

(2012) Gaetano Bertino et al.   SEMINARS IN ONCOLOGY

Immunotherapy of hepatocellular carcinoma

(2012) Angela D. Pardee et al.   OncoImmunology

Phase Ⅰ clinical study of combination therapy with microwave ablation and cellular immunotherapy in hepatocellular carcinoma

(2011) Pei Zhou et al.   CANCER BIOLOGY & THERAPY

Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review

(2011) J.-H. Zhong et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Human    T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement

(2010) A. Maniar et al.   BLOOD

Therapeutic safety and effects of adjuvant autologous RetroNectin activated killer cell immunotherapy for patients with primary hepatocellular carcinoma after radiofrequency ablation

(2010) Haiqing Ma et al.   CANCER BIOLOGY & THERAPY

Spontaneous Regression of Multiple Pulmonary Metastases After Radiofrequency Ablation of a Single Metastasis

(2010) Pramod Rao et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Do NK cells always need a license to kill?

(2010) Mario-Ernesto Cruz-Munoz et al.   NATURE IMMUNOLOGY

FOXP3 Defines Regulatory T Cells in Human Tumor and Autoimmune Disease

(2009) I. Kryczek et al.   CANCER RESEARCH

Hidden talents of natural killers: NK cells in innate and adaptive immunity

(2009) Megan A. Cooper et al.   EMBO REPORTS

Cytokine-induced killer cells are terminallydifferentiated activated CD8 cytotoxic T-EMRA lymphocytes

(2009) Marta Franceschetti et al.   EXPERIMENTAL HEMATOLOGY

Adaptive immunity in hepatocellular carcinoma: prognostic and therapeutic implications

(2009) Evangelia M Fatourou et al.   Expert Review of Anticancer Therapy

Minimally Invasive Treatment Combined With Cytokine-induced Killer Cells Therapy Lower the Short-term Recurrence Rates of Hepatocellular Carcinomas

(2009) De-Sheng Weng et al.   JOURNAL OF IMMUNOTHERAPY

Cross-presenting human    T cells induce robust CD8+    T cell responses

(2009) M. Brandes et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Tumor cell apoptosis induces tumor-specific immunity in a CC chemokine receptor 1- and 5-dependent manner in mice

(2008) Noriho Iida et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Combination of radiofrequency ablation and immunotherapy

(2007) Francesco et al.   Frontiers in Bioscience-Landmark